drugset

drugset / Trial / NCT00448227

Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex Infection

NCT00448227 ↗

Phase 2 Completed 18 enrolled Novartis

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study will evaluate the acceptability and safety of famciclovir in infants with herpes simplex infection

Timeline

Start: 2007-10
Primary completion: 2008-11
Completion: —

Publications

Blumer J, Rodriguez A, Sanchez PJ, Sallas W, Kaiser G, Hamed K. Single-dose pharmacokinetics of famciclovir in infants and population pharmacokinetic analysis in infants and children. Antimicrob Agents Chemother. 2010 May;54(5):2032-41. doi: 10.1128/AAC.01508-09. Epub 2010 Feb 16.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Famciclovir	Small molecule	—	Oral

Indications